226330 Stock Chart & Stats
₩1545.00
-₩38.00(-2.40%)
―
--
Day’s Range― - ―
52-Week Range₩1,315.00 - ₩6,750.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)287.35K
Market Cap
₩38.40B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.07
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding24,258,474
10 Day Avg. Volume612,263
30 Day Avg. Volume287,351
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-137
Revenue Forecast (FY)₩7.70B
226330 FAQ
What was SYNTEKABIO, INC.’s price range in the past 12 months?
SYNTEKABIO, INC. lowest stock price was ₩1315.00 and its highest was ₩6750.00 in the past 12 months.
What is SYNTEKABIO, INC.’s market cap?
SYNTEKABIO, INC.’s market cap is ₩38.40B.
When is SYNTEKABIO, INC.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SYNTEKABIO, INC.’s earnings last quarter?
SYNTEKABIO, INC. released its earnings results on May 15, 2026. The company reported -₩143.945 earnings per share for the quarter, beating the consensus estimate of -₩495 by ₩351.055.
Is SYNTEKABIO, INC. overvalued?
According to Wall Street analysts SYNTEKABIO, INC.’s price is currently Undervalued.
Does SYNTEKABIO, INC. pay dividends?
SYNTEKABIO, INC. does not currently pay dividends.
What is SYNTEKABIO, INC.’s EPS estimate?
SYNTEKABIO, INC.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SYNTEKABIO, INC. have?
SYNTEKABIO, INC. has 24,258,474 shares outstanding.
What happened to SYNTEKABIO, INC.’s price movement after its last earnings report?
SYNTEKABIO, INC. reported an EPS of -₩143.945 in its last earnings report, beating expectations of -₩495. Following the earnings report the stock price went down -8.491%.
Which hedge fund is a major shareholder of SYNTEKABIO, INC.?
Currently, no hedge funds are holding shares in KR:226330
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gencurix, Inc.
―
Cellid Co., Ltd.
―
Wonbiogen Co.,Ltd.
―
Genesystem Co., Ltd.
―
Oncocross Co., Ltd.
―